Participate in the OI Wellbeing Study Baylor College of Medicine is conducting this OI Wellbeing Study as a part of
Evidera, a company specialized in patient-centered outcomes research, are currently looking for individuals living with osteogenesis imperfecta (OI). Please take
Today, Ultragenyx announced Interim data from the Phase 2 portion of the Orbit study, which showed that treatment with setrusumab
  The OIF E-Newsletter is here! Click here to read this issue!  
From the BBDC: Osteogenesis Imperfecta Over Time: What We’re Learning from a Natural History Study To learn more about the
Learn more and register for the 2024 OIF National Conference today!
The September E-Newsletter is here! Click here to read this issue.
The Michael Geisman Fellowship Grant program awards funding to post-doctoral trainees who are currently working on projects with clear relevance
The August issue of E-News is here! Read about becoming a Support Group Leader, OI Research Updates, and upcoming OIF
Register for the OIF Regional Conference in Phoenix, AZ!